Submit Deal

ANGIODYNAMICS INC

HQ - New York

Summary

AngioDynamics is a global provider of industry-leading medical devices used around the world for the treatment of cancer and peripheral vascular disease.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 245 M

Avg. Deal Size£ 82 M

Market Context

Senior Management

JIm Clemmer
President and CEO
Stephen Trowbridge
Executive Vice President and CFO
Saleem Cheeks
Vice President, Communications

Sort

angiodynamics (dialysis product portfolio and biosentry product)

HQ - United States

Medical Equipment

8 Jun 2023

Investment Date

100%

Stake

£ 80 M

Deal Value

angiodynamics (picc and midline product portfolios)

HQ - United States

Medical Equipment

15 Feb 2024

Investment Date

100%

Stake

£ 35 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy